CDXDA
This asset is not currently listed on any markets available through Pearler. The information on this page may be inaccurate or out of date.
Cardiex Limited
๐ฆ๐บ ASX
๐ Overview
๐ Performance
๐ต Cost
๐ Esg
๐ค Advanced
๐จโ๐ฉโ๐งโ๐ฆ Community
๐
N/A
Annual Growth
5 years average annual growth
๐ต
$ 500
Minimum Order
Due to regulatory requirements
๐
5
Pearlers Invested
Since January 2020
๐ Overview
Key information
๐ Fund Overview
Cardiex Limited
๐ Performance
Price History
+342.86%
1M
All Time
Graph
Table
Unsure how much or often to invest?
๐๏ธ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out โ๐ต Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out โโฑ๏ธ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out โ๐ต Costs
๐ผ
N/A
Management Fee
Included in unit price, not charged by Pearler
๐ธ
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐ธ Net fee calculator๐ค Advanced information
Technical Info
๐ฐ Price*
$0.47
*Price may be up to 24 hours old
๐ฉโ๐ฉโ๐ฆ Community Insights
How our community is investing
๐ Pearlers invested in CDXDA
0
๐ Total Capital Earnings
N/A
๐ Average investment frequency
101 weeks
๐ต Average investment amount
$100
โฐ Last time a customer invested in CDXDA
1008 days
CDXDA investor breakdown
๐ต Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
๐ถ Age of investors
18 - 25
26 - 34
35 - 90
๐ Legal gender of investors
Female
Male
Pearlers who invest in CDXDA also invest in...
CardieX Ltd. engages in designing, manufacturing, and marketing medical devices used in cardiovascular health management. The company is headquartered in Sydney, New South Wales. The company went IPO on 2005-11-09. The firm develops and markets noninvasive patient monitoring technologies for assessing cardiovascular health. The company specializes in the development of biomarkers and digital solutions for large-scale cardiovascular health disorders. Its solutions are designed to be deployed at point-of-care for arterial health screening, and as part of a remote patient monitoring regimen to extend care and enhance cardiovascular health outcomes. Its suite of products includes medical and home health devices and digital solutions for hypertension, cardiovascular disease, and other vascular health disorders all based on the Companyโs SphygmoCor vascular biomarker technology. Its products include CONNEQT Pulse, SphygmoCor XCEL, and Oscar 2 Ambulatory Blood Pressure Monitor. CONNEQT Pulse measures both brachial and central blood pressures alongside a suite of vascular biomarkers to provide unparalleled insights into vascular health.
๐ Performance (5Yr p.a)
-12.22%
๐ Share price
$0.10 AUD
๐ฉบ HEALTH CARE
CDXNC
CardieX Ltd. engages in designing, manufacturing, and marketing medical devices used in cardiovascular health management. The company is headquartered in Sydney, New South Wales. The company went IPO on 2005-11-09. The company is engaged in designing, manufacturing, and marketing medical devices for use in cardiovascular health management, and the development of clinical and consumer digital health solutions. The company is focused on hypertension, cardiovascular disease, and other vascular health disorders. The company operates through its subsidiaries, including ATCOR and CONNEQT. ATCOR division provides medical devices for measuring arterial stiffness and central blood pressure waveforms based on its SphygmoCor technology. Under the ATCOR.X brand, it also develops and licenses its Arty platform consisting of physiological and health analytics for wearable devices. Its digital platform, ArtyNet, is a connected software as a service ecosystem providing physicians with a telehealth solution for remotely managing patientsโ health. CONNEQT develops and markets consumer wearable and home health devices focused on heart health and its patented fitness parameters.
๐ฉบ HEALTH CARE
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
๐ Performance (5Yr p.a)
13.23%
๐ Share price
$134.96 AUD
๐ GLOBAL
๐ค TECHNOLOGY
โณ๏ธ DIVERSIFIED
๐ HIGH PRICE GROWTH
Flight Centre Travel Group Ltd. is engaged in providing travel retailing, wholesaling and corporate travel management services. The company is headquartered in Brisbane, Queensland and currently employs 13,065 full-time employees. The firm's principal activities include travel retailing in both the leisure and corporate travel sectors, plus in-destination travel experience businesses including tour operations, hotel management, destination management companies (DMCs) and wholesaling. Its segments include Leisure, Corporate, and Other. The Leisure segment combines the retail store front and online brands for retail customers, luxury travel brands Travel Associates and Scott Dunn, independent agents and complementary offerings. The Corporate segment includes the FCM brand, Corporate Traveller and other Corporate customer brands. The Other segment includes Brisbane-based and other support businesses, including Supply, that support the global network and also include travel management services which incorporates touring, ground-handling and hotels. Its brands include Flight Centre, Aunt Betty, ignite, and Scott Dunn.
๐ Performance (5Yr p.a)
-11.14%
๐ Share price
$17.00 AUD
๐จ HOTELS, RESTAURANTS & LEISURE
VTS.AX was created on 2009-05-12 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard U.S. Total Market Shares Index ETF seeks to track the performance of the CRSP US Total Market Index, providing investors with exposure to a broadly diversified collection of securities that, in the aggregate, approximates the full index in terms of key characteristics.
๐ Performance (5Yr p.a)
18.90%
๐ Share price
$454.17 AUD
๐บ๐ธ UNITED STATES
๐ค TECHNOLOGY
โณ๏ธ DIVERSIFIED
๐ HIGH PRICE GROWTH